|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net Income (Loss) | |||||
| Adjustments to reconcile net income (loss) to net cash and cash equivalents provided by operating activities: | |||||
| Change in deferred policy acquisition costs | |||||
| Change in deferred sales inducements | |||||
| Change in value of business acquired | |||||
| Change in benefit reserves, net of change in ceded reinsurance recoverable | |||||
| Change in income tax accruals | |||||
| Change in claims and claims settlement expenses | |||||
| Change in other operating assets and liabilities - net | |||||
| Change in checks not yet presented for payment | |||||
| Amortization (accretion) of investments | |||||
| Interest credited to policyholder liabilities | |||||
| Net derivative (gains) losses | |||||
| Net realized investment (gains) losses | |||||
| Change in unrealized (gains) losses related to limited partnerships | |||||
| Net cash and cash equivalents provided by/(used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Sales of available-for-sale securities and mortgage loans | |||||
| Maturities of available-for-sale securities and mortgage loans | |||||
| Purchases of available-for-sale securities and mortgage loans | |||||
| Sales of limited partnerships | |||||
| Purchases of limited partnerships | |||||
| Change in affiliated short-term note receivable | |||||
| Cash received in connection with derivatives | |||||
| Cash paid in connection with derivatives | |||||
| Proceeds from the maturity or prepayment of policy loans | |||||
| Payments for the origination of policy loans | |||||
| Net settlement on futures contracts | |||||
| Other | |||||
| Net cash and cash equivalents provided by/(used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Policyholder deposits | |||||
| Policyholder withdrawals | |||||
| Capital contributions from AUSA | |||||
| Return of capital to TA Corp/AUSA | |||||
| Change in payables for collateral under securities loaned, reverse repurchase agreements and derivatives | |||||
| Cash dividend paid to TA Corp | |||||
| Cash receipts from affiliated short-term note payable | |||||
| Cash paid on affiliated short-term note payable | |||||
| Net cash and cash equivalents provided by/(used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...